Cargando…
Piperlongumine Inhibits Akt Phosphorylation to Reverse Resistance to Cisplatin in Human Non-Small Cell Lung Cancer Cells via ROS Regulation
Resistance is a major concern when administering chemotherapy to patients with non-small cell lung cancer (NSCLC). Chemosensitizer are agents that can reverse resistance to chemotherapeutic drugs, thereby enhancing the chemosensitivity of tumor cells. Thus, their development will improve therapeutic...
Autores principales: | Zhang, Chao, He, Lian-Jun, Zhu, Yi-Bao, Fan, Qing-Zhu, Miao, Dong-Dong, Zhang, Sheng-Peng, Zhao, Wen-Ying, Liu, Xiao-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798055/ https://www.ncbi.nlm.nih.gov/pubmed/31680961 http://dx.doi.org/10.3389/fphar.2019.01178 |
Ejemplares similares
-
Piperlongumine increases the sensitivity of bladder cancer to cisplatin by mitochondrial ROS
por: Pan, Xiaobo, et al.
Publicado: (2022) -
Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress
por: Zhang, Qianqian, et al.
Publicado: (2019) -
Corrigendum: Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress
por: Zhang, Qianqian, et al.
Publicado: (2022) -
Piperlongumine Is an NLRP3 Inhibitor With Anti-inflammatory Activity
por: Shi, Jie, et al.
Publicado: (2022) -
Piperlongumine Induces Cellular Apoptosis and Autophagy via the ROS/Akt Signaling Pathway in Human Follicular Thyroid Cancer Cells
por: Lin, Tsung-Hsing, et al.
Publicado: (2023)